Search

Search Constraints

You searched for: Date 2016

Search Results

3. Neither vaginal nor buccal administration of 800 μg misoprostol alters mucosal and systemic immune activation or the cervicovaginal microbiome: a pilot study. (1st November 2016)

5. Beliefs about medicines, doctor–patient relationship, and coping among European patients with cancer. Issue 2 (13th April 2016)

10. Psychological variables associated with quality of life following primary treatment for head and neck cancer: a systematic review of the literature from 2004 to 2015. Issue 2 (26th February 2016)